TSX Healthcare in April 2024: The Best Stocks to Buy Right Now

TSX’s healthcare sector is not as popular as the heavyweight sectors, but it has three of the best stocks you can buy in April.

| More on:
A doctor takes a patient's blood pressure in a clinical office.

Source: Getty Images

The performance of TSX’s healthcare sector in the last six months has been decent (+16.02%), and it continues to outperform the broader market year to date amid the constant spikes and dips. Emerging healthcare trends, including the adoption of artificial intelligence (AI), could boost the sector and healthcare-related businesses.

If you want to invest in the healthcare space this month, WELL Health Technologies (TSX:WELL), Knight Therapeutics (TSX:GUD), and NorthWest Healthcare Properties (TSX: NWH.UN) are the best stocks to buy right now. The companies will be around for some time, regardless of the economic environment.

Medical care facilities

WELL Health has a solid footprint in the healthcare industry because it is Canada’s largest owner and operator of outpatient health clinics. In addition to the primary healthcare facilities in the U.S. and Canada, the $862.15 million digital health technology company provides EMR (electronic medical record) services to clinics and doctors across the home country.

The current share price of $3.51 (-8.8% year to date) is relatively cheap, although based on market analysts’ 12-month average and high price targets, the upside potential is between 112.3% ($7.45) and 213.4% ($11). AI, with its endless applications for patients and medical professionals, is a growth catalyst.

In October 2023, WELL Health acquired HEALWELL’s performing clinical assets and launched WELL AI to empower healthcare providers with next-generation decision-support systems.

More importantly, the company reported a $776.1 million revenue in 2023, representing a 36% year-over-year increase. Management maintains a robust outlook for 2024 and expects annual revenue from $950 to $970 million.

Positioned for future success

Knight Therapeutics trades slightly higher than WELL ($5.42 per share), but the potential price appreciation is equally enticing. Based on market analysts’ “strong buy” recommendations, GUD could rise by as much as 40% to $7.60 in one year.

This $582.74 million specialty pharmaceutical company focused on acquiring, in-licensing, out-licensing, marketing, and commercializing innovative prescription pharmaceuticals. Knight’s primary goal is to bring branded generic products to Canada and Latin America. As of year-end 2023, it has a robust pipeline of 17 products in 11 countries.

In 2023, revenues increased 12% to $328.2 million versus 2022, while net loss thinned 44% year over year to $16.8 million. Management said Knight Therapeutics is well-positioned for future success due to its unique and profitable platform. The 17 products in the pipeline should be launch-ready by 2028 and deliver over $120 million in peak revenues.

Only REIT in the cure sector

NorthWest Healthcare is the only real estate investment trust (REIT) in the cure sector. This $1.21 billion REIT owns and manages medical office buildings, hospitals, and clinics in eight countries. The tenant base is in the healthcare, research, life sciences, and education sectors.

The REIT is a pure dividend play and ideal for income-focused investors. At $4.99 per share (-1.2% year to date), you can partake in the hefty 7.21% dividend. Management believes the REIT contributes to the highest standard of healthcare by creating and enhancing healthcare infrastructure.

Good investment options

WELL Health, Knight Therapeutics, and NorthWest Healthcare Properties are good investment options. The first two can outsized capital gains, while the third can provide recurring monthly passive-income streams.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool recommends NorthWest Healthcare Properties Real Estate Investment Trust. The Motley Fool has a disclosure policy.

More on Dividend Stocks

edit Balloon shaped as a heart
Dividend Stocks

Love Value Stocks? 2 That Are Screaming Buys in May 2024

Patience can pay off by investing in these two value stocks with nice dividends and the potential to turn around.

Read more »

Senior Couple Walking With Pet Bulldog In Countryside
Dividend Stocks

2 Everlasting Canadian Stocks for Your RRSP

The Canadian National Railway (TSX:CNR) stock is worth owning for the long haul.

Read more »

Business success with growing, rising charts and businessman in background
Dividend Stocks

3 Stocks Set for Dividend Increases This Year

Here are three TSX stocks that are set to increase their dividends later this year.

Read more »

Dice engraved with the words buy and sell
Dividend Stocks

EQB Inc Stock: Buy, Sell, or Hold

EQB Inc (TSX:EQB) is Canada's fastest-growing bank.

Read more »

pipe metal texture inside
Dividend Stocks

Enbridge Stock: Buy, Sell, or Hold Today?

Enbridge is up 7% in the past six months. Are more gains on the way?

Read more »

money cash dividends
Dividend Stocks

The 2 Stocks Every Dividend Investor Should Own for Reliable Cash

Dividend stocks offering consistent and reliable returns can be a crucial asset in any portfolio, especially for income-producing dividend portfolios.

Read more »

grow dividends
Dividend Stocks

2 Dividend Stocks to Double Up on Right Now

These top TSX dividend-growth stocks now offer yields above 7%.

Read more »

Dollar symbol and Canadian flag on keyboard
Dividend Stocks

TFSA: 2 Canadian Stocks to Buy and Hold for Tax-Free Gains

Building a large, tax-free nest egg in your TFSA with growth stocks can give you more control over your tax…

Read more »